The pharma company’s newer immunology drugs, Skyrizi and Rinvoq, have delivered robust sales growth that’s proving to be the tide that lifts all boats. Newer neuroscience products like Vraylar and …
2 Healthcare Stocks for Individual Investors With a 10-Year Time Horizon
view original post